Why Amwell’s CEO isn’t completely discouraged by its stock price

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why Amwell's CEO Isn't Completely Discouraged By Its Stock Price Amwell CEO Roy Schoenberg thinks the stock market has adopted a rather simplistic view of telehealth over the past year, reducing the care modality to a pandemic-era trend in which patients are no longer interested. But Schoenberg pointed out that providers are still committed to virtual care. Because of this, he thinks his company is in a better position to raise its stock price than others because it is partnering directly with providers to evolve telehealth delivery models. "The Best Event" Get Your Front Row Seat Don't take our word for it. Past attendees comment on the event. J. June, CEO of Ischemia Care, said, "Great networking, venue was outstanding, a lot of fun. This was without a doubt the best event of its type I have ever attended." And P. Burton, CEO of ResQ Pharma, said, "Very well managed. Speakers and panelists were outstanding. Content and subject matters covered during presentations were excellent. Overall I had an outstanding experience!" Hurry, You Can Still Save $400 [Ends 4/7] - Register Today!

Featured News

StartUPDATES: New Developments from Healthcare Startups Check out news from VenoVision, Cora Therapeutics, Zorro, and Validic. Get To Know the 23 Startups AWS Chose for Its Workforce Development Accelerator Last fall, AWS announced that it was launching a new accelerator to support startups that develop technology to help the healthcare sector address its challenges with workforce deployment, retention and training. At ViVE, the company unveiled which 23 startups have been selected to take part in the accelerator. Ohio Sues Express Scripts, Cigna, Prime Therapeutics and Humana Calling PBMs "Modern Gangsters" The complaint alleges multiple violations of the Valentine Act, Ohio's antitrust law, which prohibits price fixing, controlled sales and other agreements that restrain trade and hurt competition. David Yost, the attorney general decried the practices of PBMs saying that they hurt everyday Ohioans dependent on life-saving drugs like insulin. When It Comes to Radiology, What Can We Teach ChatGPT ? The potential of ChatGPT is exciting. Radiologists have come a long way on the AI journey. What started as a fear from some that AI would replace us, has evolved to a more nuanced understanding that AI's greatest contribution in medical imaging is to make us better radiologists. GSK Strikes Another Antimicrobial Deal, Paying $90M for Scynexis's Brexafemme GSK acquired global rights to Brexafemme, a novel antifungal from Scynexis that is approved for treating vaginal yeast infections. The deal also gives GSK the chance to commercialize the drug in other indications. MedCity Pivot: Blue Shield of California CEO Says Value of HealthTech Has Been Mixed So Far Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company's Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid. How Remote Patient Monitoring Can Help Advance Health Equity The recent growth in RPM has demonstrated its importance and potential to reduce or eliminate barriers and improve access to care for patients. By leveraging RPM and other digital health solutions as an important part of a multi-prong approach to care delivery, a future where all patients have equal access to high-quality healthcare becomes a closer reality.

Resources

10 Ways to Decode Silicon Valley Bank Collapse Shared with you in the form of 10 questions to encourage probing further into what happened and how it could have been prevented. Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe